VVynca provides a healthcare platform for advance care planning, ensuring patients' end-of-life wishes are documented and accessible across hospitals, ICUs, and post-acute care settings. It serves ACOs, payers, providers, and state registries through a subscription model, giving organizations ongoing access to the platform and services. The system coordinates care by recording patient preferences and making them available to clinicians across the care continuum, which has been associated with reductions in hospital and ICU admissions (39? Wait: the data says 37% reduction in hospital admissions and 59% reduction in ICU admissions). The platform helps align care with patient choices across the healthcare continuum in the United States. The goal is to improve the quality of end-of-life care by prioritizing patient choices and enabling consistent care coordination across settings.
Work here?Claim your company
Industries
Company Size
51-200
Company Stage
Late Stage VC
Total Funding
$40.3M
Headquarters
Palo Alto, CA
Founded
2013
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$40.3M
Above
Industry Average
Funded Over
2 Rounds
Vynca named to the 2026 Inc. 5000 List, the most prestigious ranking of America's fastest-growing private companies. Business Wire SAN FRANCISCO, August 11, 2026-(BUSINESS WIRE)-Vynca, a healthcare company transforming care for people living with serious illness and complex needs, today announced it has been named on the 2026 Inc. 5000 list, the annual list of the fastest-growing private companies in America. The list is the most prestigious ranking of the nation's most successful independent and entrepreneurial businesses, recognizing companies that have achieved remarkable growth while driving innovation, creating jobs, and shaping the future of the economy. Past honorees include companies such as Microsoft, Meta, Chobani, Oracle, and Patagonia. "Our company's growth and this recognition reflect our team's dedication and hard work in providing palliative care across the country - it's validation that our care delivery model works for the patients and families who need it most," said Darren Schulte, MD, Chief Executive Officer of Vynca. "Our success belongs to our entire team caring for people living with life-limiting serious illness, helping them have more quality days at home. That is the metric that matters most to us." This year's Inc. 5000 recognizes a new class of companies redefining what growth looks like. From AI and advanced manufacturing to healthcare, consumer products, and professional services, these businesses are expanding their impact, creating jobs and proving that entrepreneurial ambition continues to fuel the U.S. economy. Among the 5,000 companies on the list, the median three-year revenue growth rate was 130%, and those companies have collectively added more than 627,208 jobs to the U.S. economy over the past three years. For the full Inc. 5000 list, honoree company profiles, and a searchable database by industry and location, please visit: www.inc.com/inc5000. "Every company on the Inc. 5000 has a story of perseverance, smart decision making, and a refusal to sit still," says Mike Hofman, editor-in-chief of Inc. "Their growth reflects more than strong financial performance-it reflects creativity, resilience, and the customer focus required to build companies that make a lasting impact. We congratulate all honorees on this significant achievement." Inc. will celebrate the honorees at the 2026 Inc. 5000 Conference & Gala, taking place October 14-16 in Dallas, Texas and the top 500 will be listed in the Fall issue of Inc. Magazine. Tickets are on sale now. Inc. 5000 List Methodology Companies on the 2026 Inc. 5000 are ranked according to percentage revenue growth from 2022 to 2025. To qualify, companies must have been founded and generating revenue by March 31, 2022. They must be U.S.-based, privately held, for-profit, and independent - not subsidiaries or divisions of other companies - as of December 31, 2025. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2022 is $100,000; the minimum for 2025 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons.
Vynca, a health technology company supporting individuals with serious illness, has appointed Jill Schwartz-Chevlin as Chief Medical Officer. Dr Schwartz-Chevlin will lead clinical strategy, integrating tech-enabled palliative care and predictive analytics to improve patient outcomes whilst reducing care utilisation for health plans. Dr Schwartz-Chevlin brings over 20 years' experience in home-based, value-based care models. Most recently, she served as Chief Medical Officer for Serious Illness at WellBe Senior Medical, overseeing palliative care for more than 50,000 patients across nine states and achieving a 40% reduction in hospital utilisation. Previously at Landmark Health, she scaled national palliative care programmes across 20-plus states, covering over 60,000 lives and reducing medical costs by 26% for highest-risk populations. Vynca has demonstrated a 43% reduction in emergency department visits and 52% reduction in hospital admissions.
SAN FRANCISCO, July 15, 2025 /PRNewswire/ - Vynca, a healthcare services and software company that cares for individuals with serious illnesses and complex needs, today announced that Sandra Clarke was appointed to its Board of Directors in June 2025.
SAN FRANCISCO, March 4, 2025 /PRNewswire/ - Vynca, a healthcare services and software company that cares for individuals with serious illnesses and complex needs, today announced the appointment of Chad Baugh as Chief Commercial Officer and Paige Swanepoel as Senior Vice President of Marketing.
Successful Healthcare Technology Entrepreneurs Will Accelerate VyncaCare's Growth and ScaleSAN FRANCISCO, June 28, 2023 /PRNewswire/ -- VyncaCare, a serious illness management company, announced the appointment of Darren Schulte, MD, as the Chief Executive Officer and Board Director and James P. Bradley as Chairman of the Board of Directors. Dr. Schulte succeeds co-founder Ryan Van Wert, MD, who steps down after a decade of leading VyncaCare.There's a tremendous opportunity to build on the positive impact VyncaCare has made on physician and patient experience Tweet this Darren Schulte, MD | Chief Executive Officer James P. Bradley | Board ChairVyncaCare has realized significant growth over the past several years. The company offers a unique palliative care model that addresses the physical, spiritual, and psychosocial needs of vulnerable and underserved patients living with serious illnesses."It has been a privilege to serve as CEO of VyncaCare, and I am proud of what we have accomplished," said Dr
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
51-200
Company Stage
Late Stage VC
Total Funding
$40.3M
Headquarters
Palo Alto, CA
Founded
2013
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs